Correlation of Hepatitis C, Alcoholic Liver Disease, and Renal Failure With Hyperfibrinolysis in Liver Failure

Scott Allen54 enrolled

Overview

1. Further characterize the incidence of hyperfibrinolysis in cirrhotics 2. Correlate hyperfibrinolysis with 1. hepatitis C 2. alcoholic liver disease 3. the subset of a\&b with renal failure with and without dialysis 3. Better describe the hyperfibrinolytic ROTEM profile in cirrhotics

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cirrhosis

Interventions

RotemOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Be on the the liver transplant waiting list Exclusion Criteria: * liver failure without eligibility for transplant

Locations (1)

University of Utah

Salt Lake City, Utah, United States

Outcomes

Primary Outcomes

The percentage of patients who exhibit fibrinolysis

The percentage of patients who exhibit fibrinolysis, defined as a decrease in maximum clot firmness \<15% within 60 minutes of sample run time.

Time frame: Within 60 minutes of sample run time

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.